Invus Group’s most common sectors for investment areinternet software and services (23%) and retail (12%) . The Firm’s most common investment types include growth capital (23%) and recapitalization (23%). In total, Invus Group has invested in 6 US states and 2 different countries.
Sign-up to view Invus Group’s full profile and discover more mega-sized private equity firm investors just like it.
750 Lexington Avenue, 30th Floor,
New York,
New York
10022
United States
(212) 371-1717
www.invus.com
nyoffice@invus.com
| Status | Dates | Company | Description | |
|---|---|---|---|---|
| Investment | Exit | |||
| Current | 2021-03-01 | - |
Parabilis Medicines
Life Science Cambridge, Massachusetts www.parabilismed.com |
Parabilis Medicines is a biopharmaceutical company with a mission to drastically reduce the burden of disease on patients and their families by inventing new types of drugs that squelch abnormal physiological processes in ways previously imagined but considered unattainable. The company is pioneering the discovery, development and commercialization of Helicon peptides, a new drug modality that uniquely combines the cell-permeability and oral dosing optionality of traditional small molecule drugs with the high specificity, broad target accessibility and rapid discovery arc of monoclonal antibody drugs. Parabilis Medicines was founded in 2016 and is based in Cambridge, Massachusetts.
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
